Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Quanzhou

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: L/C

    Tamoxifen citrate is a competitive antagonist of estrogen. It is a non-steroidal anti-estrogen drug. It can compete with estrogen (estradiol) in vivo and bind with estrogen in breast cancer cells by Chemicalbook body, thereby inhibiting the effect of estrogen on cancer cells, hindering the growth and development of tumor cells, and exerting anti-cancer effects. It is often used clinically to treat various types of breast cancer, especially in postmenopausal breast cancer women with positive estrogen receptors and progesterone receptors and low levels of prostate-specific antigens.

Send your message to this supplier
  • From:
  • To:
    Quanzhou Fortune Biopharma Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service